Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 2/2019

21.07.2018 | Original Article

Treatment history and association between allergic rhinitis symptoms and quality of life

verfasst von: Marlene M. Speth, Lloyd P. Hoehle, Katie M. Phillips, David S. Caradonna, Stacey T. Gray, Ahmad R. Sedaghat

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Recalcitrance of allergic rhinitis (AR) to medical management may be reflective of patient-specific impact of AR symptoms.

Aims

To understand the relationship between AR symptoms and general health-related quality of life (QOL) or AR control, based on treatment status.

Methods

Cross-sectional cohort study of 130 adult participants—65 using no allergy medications and 65 consistently using intranasal corticosteroid sprays (ICS) in the last 3 months—presenting with persistent AR. General health-related QOL was measured using the EuroQol 5-dimensional visual analog scale (EQ-5D VAS). Severity and control of AR symptoms were measured using the 22-item Sinonasal Outcome Test (SNOT-22) and the Rhinitis Control Assessment Test (RCAT), respectively. We compared associations between AR symptoms and general health-related QOL and AR control in patients presenting with persistent AR with and without ICS use.

Results

Severity of AR symptoms was similar between cohorts. In participants using no allergy medications, extranasal AR symptom severities were most dominantly associated with decreased EQ-5D VAS and RCAT score. In participants using ICS, only nasal symptom severities were associated with decreased EQ-5D VAS and RCAT scores. Consistently, only in participants on ICS was a deviated septum associated with decreased EQ-5D VAS (β = − 12.1, 95% CI − 21.1 to − 3.1, p = 0.011) and poorly controlled AR (OR = 4.27, 96% CI 1.27 to 14.33; p = 0.019).

Conclusions

In persistent AR despite consistent ICS use, nasal symptoms may be the dominant drivers of AR-associated decreased general health-related QOL in contrast to persistent AR on no medication, when extranasal symptoms of AR are most significant. Longitudinal study is needed to investigate whether these results are predictive of responsiveness to ICS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bousquet J, Khaltaev N, Cruz AA et al (2008) Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(Suppl 86):8–160CrossRefPubMed Bousquet J, Khaltaev N, Cruz AA et al (2008) Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(Suppl 86):8–160CrossRefPubMed
2.
Zurück zum Zitat Hellgren J, Cervin A, Nordling S et al (2010) Allergic rhinitis and the common cold—high cost to society. Allergy 65(6):776–783CrossRefPubMed Hellgren J, Cervin A, Nordling S et al (2010) Allergic rhinitis and the common cold—high cost to society. Allergy 65(6):776–783CrossRefPubMed
3.
Zurück zum Zitat Price D, Scadding G, Ryan D et al (2015) The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey. Clin Transl Allergy 5:6 eCollection 2015CrossRef Price D, Scadding G, Ryan D et al (2015) The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey. Clin Transl Allergy 5:6 eCollection 2015CrossRef
5.
Zurück zum Zitat Canonica GW, Bousquet J, Mullol J et al (2007) A survey of the burden of allergic rhinitis in Europe. Allergy 62(Suppl 85):17–25CrossRefPubMed Canonica GW, Bousquet J, Mullol J et al (2007) A survey of the burden of allergic rhinitis in Europe. Allergy 62(Suppl 85):17–25CrossRefPubMed
6.
Zurück zum Zitat Bauchau V, Durham SR (2004) Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 24(5):758–764CrossRefPubMed Bauchau V, Durham SR (2004) Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 24(5):758–764CrossRefPubMed
7.
Zurück zum Zitat Seidman MD, Gurgel RK, Lin SY et al (2015) Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg 152(1 Suppl):1CrossRef Seidman MD, Gurgel RK, Lin SY et al (2015) Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg 152(1 Suppl):1CrossRef
8.
Zurück zum Zitat Jordana G, Dolovich J, Briscoe MP et al (1996) Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol 97(2):588–595CrossRefPubMed Jordana G, Dolovich J, Briscoe MP et al (1996) Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol 97(2):588–595CrossRefPubMed
9.
Zurück zum Zitat Sedaghat AR, Busaba NY, Cunningham MJ et al (2013 Jan) Clinical assessment is an accurate predictor of which patients will need septoplasty. Laryngoscope 123(1):48–52CrossRefPubMed Sedaghat AR, Busaba NY, Cunningham MJ et al (2013 Jan) Clinical assessment is an accurate predictor of which patients will need septoplasty. Laryngoscope 123(1):48–52CrossRefPubMed
10.
Zurück zum Zitat Blaiss MS, Benninger MS, Fromer L et al (2006) Expanding choices in intranasal steroid therapy: summary of a roundtable meeting. Allergy Asthma Proc 27(3):254–264CrossRefPubMed Blaiss MS, Benninger MS, Fromer L et al (2006) Expanding choices in intranasal steroid therapy: summary of a roundtable meeting. Allergy Asthma Proc 27(3):254–264CrossRefPubMed
11.
Zurück zum Zitat Hoehle LP, Speth MM, Phillips KM et al (2017) Association between symptoms of allergic rhinitis with decreased general health-related quality of life. Am J Rhinol Allergy 31(4):235–239CrossRefPubMed Hoehle LP, Speth MM, Phillips KM et al (2017) Association between symptoms of allergic rhinitis with decreased general health-related quality of life. Am J Rhinol Allergy 31(4):235–239CrossRefPubMed
12.
Zurück zum Zitat Blaiss MS, Dykewicz MS, Skoner DP et al (2014) Diagnosis and treatment of nasal and ocular allergies: the Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys. Ann Allergy Asthma Immunol 112(4):8.e1CrossRef Blaiss MS, Dykewicz MS, Skoner DP et al (2014) Diagnosis and treatment of nasal and ocular allergies: the Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys. Ann Allergy Asthma Immunol 112(4):8.e1CrossRef
13.
Zurück zum Zitat Schatz M, Meltzer EO, Nathan R et al (2010) Psychometric validation of the rhinitis control assessment test: a brief patient-completed instrument for evaluating rhinitis symptom control. Ann Allergy Asthma Immunol 104(2):118–124CrossRefPubMed Schatz M, Meltzer EO, Nathan R et al (2010) Psychometric validation of the rhinitis control assessment test: a brief patient-completed instrument for evaluating rhinitis symptom control. Ann Allergy Asthma Immunol 104(2):118–124CrossRefPubMed
14.
Zurück zum Zitat Pynnonen MA, Kim HM, Terrell JE (2009) Validation of the Sino-Nasal Outcome Test 20 (SNOT-20) domains in nonsurgical patients. Am J Rhinol Allergy 23(1):40–45CrossRefPubMed Pynnonen MA, Kim HM, Terrell JE (2009) Validation of the Sino-Nasal Outcome Test 20 (SNOT-20) domains in nonsurgical patients. Am J Rhinol Allergy 23(1):40–45CrossRefPubMed
15.
Zurück zum Zitat EuroQol Group (1990) EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 16(3):199–208CrossRef EuroQol Group (1990) EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 16(3):199–208CrossRef
16.
Zurück zum Zitat R Development Core Team (2011) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna R Development Core Team (2011) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
17.
Zurück zum Zitat Bousquet PJ, Demoly P, Devillier P et al (2013) Impact of allergic rhinitis symptoms on quality of life in primary care. Int Arch Allergy Immunol 160(4):393–400CrossRefPubMed Bousquet PJ, Demoly P, Devillier P et al (2013) Impact of allergic rhinitis symptoms on quality of life in primary care. Int Arch Allergy Immunol 160(4):393–400CrossRefPubMed
18.
Zurück zum Zitat Bousquet PJ, Bachert C, Canonica GW et al (2010) Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial. J Allergy Clin Immunol 126(3):5CrossRef Bousquet PJ, Bachert C, Canonica GW et al (2010) Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial. J Allergy Clin Immunol 126(3):5CrossRef
19.
Zurück zum Zitat Virchow JC, Kay S, Demoly P et al (2011) Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients—an observational, cross sectional study in four countries in Europe. J Med Econ 14(3):305–314CrossRefPubMed Virchow JC, Kay S, Demoly P et al (2011) Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients—an observational, cross sectional study in four countries in Europe. J Med Econ 14(3):305–314CrossRefPubMed
20.
Zurück zum Zitat Hiraki N, Suzuki H, Udaka T et al (2008) Snoring, daytime sleepiness, and nasal obstruction with or without allergic rhinitis. Arch Otolaryngol Head Neck Surg 134(12):1254–1257CrossRefPubMed Hiraki N, Suzuki H, Udaka T et al (2008) Snoring, daytime sleepiness, and nasal obstruction with or without allergic rhinitis. Arch Otolaryngol Head Neck Surg 134(12):1254–1257CrossRefPubMed
21.
Zurück zum Zitat Skoner AR, Skoner KR, Skoner DP (2009) Allergic rhinitis, histamine, and otitis media. Allergy Asthma Proc 30(5):470–481CrossRefPubMed Skoner AR, Skoner KR, Skoner DP (2009) Allergic rhinitis, histamine, and otitis media. Allergy Asthma Proc 30(5):470–481CrossRefPubMed
22.
Zurück zum Zitat Wallace DV, Dykewicz MS, Bernstein DI et al (2008) The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 122(2 Suppl):1CrossRef Wallace DV, Dykewicz MS, Bernstein DI et al (2008) The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 122(2 Suppl):1CrossRef
23.
Zurück zum Zitat Kaszuba SM, Baroody FM, deTineo M et al (2001) Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Intern Med 161(21):2581–2587CrossRefPubMed Kaszuba SM, Baroody FM, deTineo M et al (2001) Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Intern Med 161(21):2581–2587CrossRefPubMed
Metadaten
Titel
Treatment history and association between allergic rhinitis symptoms and quality of life
verfasst von
Marlene M. Speth
Lloyd P. Hoehle
Katie M. Phillips
David S. Caradonna
Stacey T. Gray
Ahmad R. Sedaghat
Publikationsdatum
21.07.2018
Verlag
Springer London
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 2/2019
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-018-1866-2

Weitere Artikel der Ausgabe 2/2019

Irish Journal of Medical Science (1971 -) 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.